Author | Lightnews

Mauro Loi @isteddos.bsky.social · Jul 20

Microbiota and radiation from the basics 👍👍
www.nature.com/articles/s41...

The microbiota in radiotherapy-induced cancer immunosurveillance - Nature Reviews Clinical Oncology

Radiotherapy has an established role in the treatment of many patients with cancer, with evidence suggesting that this modality can also have immunostimulatory effects in certain scenarios. More recen...

www.nature.com

Reposted by Mauro Loi

Lucathequietone @lucathequietone.bsky.social · Jul 13

Today he's on fire!

Mario Ricciardi @marioricciardi.bsky.social · Jul 13

Oggi su @mm-ilmanifesto-bot.bsky.social

2 6

Reposted by Mauro Loi

Matthias Guckenberger @mguckenberger.bsky.social · Dec 5

In case you may have missed any of the

Virtual Grand Rounds in Radiation Oncology lectures

Recordings are 👇
youtube.com/playlist?lis...

Endorsed by:
ESTRO
DEGRO
SASRO

1 8 23

Reposted by Mauro Loi

Matthias Guckenberger @mguckenberger.bsky.social · May 25

Fresh from #ASCO2025
meetings.asco.org/abstracts-pr...
SBRT vs microwave ablation (MWA) in pts with CRC liver oligo-mets
➡️ n=100, n=92 treated (39 SBRT, 53 MWA)
➡️ 18/92 pts (20%) reported side effects
➡️ n=3 G3-4 pain; n=2 infections after open MWA, n=1 bowelperforation after percutaneous MWA

Program Guide – ASCO Meeting Program Guide

meetings.asco.org

1 2 1

Mauro Loi @isteddos.bsky.social · Jul 20

Proud to contribute to this important study on TNT for rectal cancer led by Francesco Sclafani 👇

pubmed.ncbi.nlm.nih.gov/40638097/

Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer - PubMed

The findings of this case series study show substantial variation in the choice of the TNT regimen and were overall aligned with those reported in clinical trials, suggesting the efficacy of TNT in a ...

pubmed.ncbi.nlm.nih.gov

Mauro Loi @isteddos.bsky.social · Jul 20

Ureter tolerance to SBRT: challenging current dose constraints! Great collaboration led by Lucy Van Werkhoven 👇

linkinghub.elsevier.com/retrieve/pii...

Redirecting

linkinghub.elsevier.com

Mauro Loi @isteddos.bsky.social · Jan 24

Bayesian Design in a nutshell #GI25

Mauro Loi @isteddos.bsky.social · Jan 24

Great presentation by Nina Niu Sanford on the role of RT in multimodal management of esophageal cancer

Mauro Loi @isteddos.bsky.social · Jan 23

Great presentation on TNT applicability in Gastric Cancer by Travis Grotz (Mayo Clinics) #GI25

Mauro Loi @isteddos.bsky.social · Jan 23

Florence Radiation Oncology team at ASCO GI25!

1

Mauro Loi @isteddos.bsky.social · Jan 21

Maintaining first-line therapy plus radiotherapy may prolong progression-free survival and delay second-line therapy for oligoprogressive hepatocellular carcinoma - International Journal of Radiation Oncology, Biology, Physics www.redjournal.org/article/S036...

Maintaining first-line therapy plus radiotherapy may prolong progression-free survival and delay second-line therapy for oligoprogressive hepatocellular carcinoma

: Optimal treatment strategies for patients with hepatocellular carcinoma (HCC) with oligoprogression after first-line systemic therapy (FLST) remain undefined. We aimed to determine if maintaining [i...

www.redjournal.org

Reposted by Mauro Loi

Henning Willers, MD, FASTRO @henningwillersmd.bsky.social · Jan 19

Because crossposting on X + BlueSky is all the rage😂...

Excited, & grateful🙏, to have my first ever #RedJournal Podcast in the👜

Also happened to be only the SECOND #RadBio Podcast ever❓Clearly we need to ⬆️ that😅 #RadBio4TheMasses

Stay tuned‼️
🙏

➡️https://www.redjournal.org/multimedia/audio

1 5 8

Mauro Loi @isteddos.bsky.social · Jan 6

"Chi sa fa, chi non sa fare coordina". Poor decision making in the hands of incompetent, inept management spiraled into the current situation

t.co/zln79XdRPe

https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(24)00375-2/fulltext

t.co

Mauro Loi @isteddos.bsky.social · Dec 14

Hora Est! So grateful to Erasmus MC for granting me the opportunity to defend my PhD on 10/12/2024! Thanks to my beautiful paranymphs Linda Rossi and Alba Magallón Baro and promoters Prof Hoogeman and Dr Nuyttens! Thanks to all my friends for being there ❤️

Mauro Loi @isteddos.bsky.social · Dec 14

Single-modality endocrine therapy versus #radiotherapy after breast-conserving surgery in women aged 70 years and older with luminal A-like early #BreastCancer (EUROPA)
@TheLancetOncol

▶️ Share Link – 50 days' free access to the article (Jan 31, 2025):
t.co/jedNdGzeE7

Mauro Loi @isteddos.bsky.social · Dec 1

x.com/cristian_udo...